Revisão sistemática sobre os modelos tridimensionais de cultura de células de gliobastoma: aplicações, vantagens e desvantagens
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Abstract
Glioblastoma (GBM) is one of the types of neoplasms with the greatest impact
and lethality in humanity. The studies developed that tested medicines and treatments for
many years faced barriers in vivo and the inability of 2D culture models to faithfully
represent interactions. From this, 3D cultivation models emerge as a viable, low-cost
alternative capable of being used to simulate physiological conditions more reliably.
Within this type of cultivation, several models have been proposed for glioblastoma.
Therefore, the objective of this study is to examine different types of 3D culture models
used in the treatment of glioblastomas. To this end, a search was carried out in several
databases between the years 2020 and 2024 using the following descriptors “3D culture”
and “glioblastoma” and “advantages of 3D culture”; or “glioblastoma” and
“disadvantages of 3D culture”; or “glioblastoma” and “application of 3D culture”. The
bibliographic search with the descriptors generated 2299 articles. After reading the titles
and summary/abstract, 2269 articles were excluded, the remaining 30 publications were
read in full and 25 were considered eligible to prepare this review, as 5 works were review
articles. Of the 25 publications, different 3D culture models were found, such as spheroids
(5 articles), organoids (5 articles), 3D bioprinting (4 articles), microfluidics (4 articles),
tumorospheres (3 articles), organotypic slices (3), tumoroid (2), explants (1 article).All
3D models described in this review provide excellent tools to better understand GBM
biology and predict drug response. However, there are still limitations to fulfill all GBM
criteria in vivo and reduce the gap leading to clinical trial failure. These models propose
a reproduction of tumor cytoarchitecture and cellular heterogeneity or the surrounding
healthy brain microenvironment. The combination of both can open up the possibility of
creating and elaborating more accurate models. The 3D models are important tools for
understanding GBM biology and predicting drug responses, but they still have limitations
in fully reproducing in vivo conditions and overcoming failures in clinical trials.
Combining these approaches can lead to the development of more accurate models.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

